NIH-funded research R21 grant

Stem cell exosomes to probe immune cell problems in ME/CFS

Official title: MSC exosomes as probes for ME/CSF immune cell dysfunction

Funded at Nova Southeastern University · NIH-11237600 · Data updated 2026-11-12

This project tests whether tiny packets from bone‑marrow stem cells can reveal immune and energy problems in people with ME/CFS.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNova Southeastern University
NIH-funded
Lab location1 site (Fort Lauderdale-Davie, UNITED STATES)
Project startDecember 1, 2024
Project endNovember 30, 2026
Funding year2026
Award (this year)$192,500
NIH project number5R21AI187895-02
Project IDNIH-11237600 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a confirmed clinical diagnosis of ME/CFS who are willing to provide blood samples (and possibly cerebrospinal fluid if requested) would be the best candidates.

Less likely to help

People without ME/CFS or those unwilling to provide biospecimens would not be eligible and are unlikely to benefit from participation.

What this research studies

You would be asked to help researchers study tiny vesicles called exosomes made by bone‑marrow mesenchymal stem cells and how they interact with immune cells and body fluids linked to ME/CFS. In the lab, scientists will expose patient immune cells (and possibly cerebrospinal fluid samples) to these exosomes to see whether they change immune activity or cellular energy processes. The team will analyze proteins, RNAs, and cell behavior to map immune and metabolic dysfunction that may underlie symptoms. Some parallel experiments may use animal models to test mechanisms and safety before human applications.

Why it matters

Potential benefit: If successful, this work could identify immune or metabolic signatures that point to new targeted treatments or diagnostic tests for ME/CFS.

How similar studies have gone: MSC‑derived exosomes have shown immune‑modulating and tissue‑protective effects in several animal models and early human research, but applying them specifically to ME/CFS is largely new.

Where this research is happening

  • Nova Southeastern University
    Fort Lauderdale-Davie, United States
    Active

Researchers

  • Principal investigator: Beljanski, Vladimir — Nova Southeastern University
  • Study coordinator: Beljanski, Vladimir

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.